Brooke Huang, PharmD, is senior commercial biopharma and medtech executive with a unique combination of medical, clinical and commercial expertise. As SVP of Global Product and Portfolio Strategy at Novocure, Brooke established the company’s first long-term strategic and commercialization plans to maximize the commercial potential of its innovative medical device to treat cancer. Her strategic foresight and planning prepared the organization for the global launch of four oncology indications, and she delivered growth across markets leading the accelerated launch in glioblastoma. Brooke’s experience includes leadership roles at Daiichi Sankyo and Sanofi. At Sanofi, she focused on medical affairs, driving education and communications strategies across cardiovascular and thrombosis areas. She optimized lifecycle management and US and global commercialization strategies while at Daiichi Sankyo. She completed a Rutgers PharmD Fellowship at Bristol-Myers Squibb in Medical Strategy.

Brooke is a Limited Partner with Portfolia and How Women Invest. She is currently providing consulting expertise as Founder of BioMed Architects LLC for portfolio optimization, global commercialization and operational support in rare disease, oncology and bioelectronic medicine.

Brooke holds a PharmD from Purdue University and completed Kellogg Executive Education in Leadership at Northwestern. She is on the Dean’s Advisory Council and the Leaders and Entrepreneurs Advancing Pharmacy (LEAP) Advisory Council for the Purdue University College of Pharmacy.